Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Perseus Proteomics Inc (4882)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
333.00 -14.00    -4.03%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3836800007 
  • Volume: 288,300
  • Bid/Ask: 333.00 / 335.00
  • Day's Range: 331.00 - 345.00
Perseus Proteomics 333.00 -14.00 -4.03%

4882 Balance Sheet

 
Featured here, the Balance Sheet for Perseus Proteomics Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 1753 1946 2109 2514
Cash and Short Term Investments 1663 1866 2036 2444
Cash - - - -
Cash & Equivalents 1663 1866 2036 2444
Short Term Investments - - - -
Total Receivables, Net 71 58 43 50
Accounts Receivables - Trade, Net 13 14 10 9
Total Inventory 2 3 2 3
Prepaid Expenses 8 10 12 7
Other Current Assets, Total 9 9 16 10
Total Assets 1796 1989 2152 2566
Property/Plant/Equipment, Total - Net - - - -
Property/Plant/Equipment, Total - Gross - - - 125.1
Accumulated Depreciation, Total - - - -125.1
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 42 42 42 51
Note Receivable - Long Term 58 44 33 41
Other Long Term Assets, Total 1 1 1 1
Other Assets, Total -60 -46 -25 -37
Total Current Liabilities 99 96 83 111
Accounts Payable 1 - 1 1
Payable/Accrued - - - -
Accrued Expenses 66 47 27 28
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 32 49 55 82
Total Liabilities 241 206 168 170
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 142 110 85 59
Total Equity 1555 1783 1984 2396
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1953 1939 1939 1939
Additional Paid-In Capital 2238 2225 2225 2225
Retained Earnings (Accumulated Deficit) -2698 -2432 -2221 -1799
Treasury Stock - Common - - -0.02 -0.02
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 62 51 41 31
Total Liabilities & Shareholders' Equity 1796 1989 2152 2566
Total Common Shares Outstanding 11.79 11.76 11.76 11.76
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4882 Comments

Write your thoughts about Perseus Proteomics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email